BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 16145062)

  • 1. Pharmacogenomic discovery approaches: will the real genes please stand up?
    Walgren RA; Meucci MA; McLeod HL
    J Clin Oncol; 2005 Oct; 23(29):7342-9. PubMed ID: 16145062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacogenomics genomics approaches to optimizing drug therapy].
    Shi J; Chen S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Apr; 19(2):156-8. PubMed ID: 11941596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of pharmacogenomics.
    Somogy A
    Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis.
    Byun E; Caillier SJ; Montalban X; Villoslada P; Fernández O; Brassat D; Comabella M; Wang J; Barcellos LF; Baranzini SE; Oksenberg JR
    Arch Neurol; 2008 Mar; 65(3):337-44. PubMed ID: 18195134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacogenomics: the quest for individualized therapy].
    López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME
    Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics: from bedside to clinical practice.
    Marsh S; McLeod HL
    Hum Mol Genet; 2006 Apr; 15 Spec No 1():R89-93. PubMed ID: 16651374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug development.
    Lee W; Lockhart AC; Kim RB; Rothenberg ML
    Oncologist; 2005 Feb; 10(2):104-11. PubMed ID: 15709212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From pharmacogenetics to pharmacogenomics: the start of a new era of personalized medicine in nephrology].
    Zaza G; Granata S; Mangino M; Grandaliano G; Schena FP
    G Ital Nefrol; 2010; 27(4):353-66. PubMed ID: 20672232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of single-nucleotide polymorphism maps in pharmacogenomics.
    McCarthy JJ; Hilfiker R
    Nat Biotechnol; 2000 May; 18(5):505-8. PubMed ID: 10802616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics: bench to bedside.
    Weinshilboum R; Wang L
    Nat Rev Drug Discov; 2004 Sep; 3(9):739-48. PubMed ID: 15340384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomic applications in clinical drug development.
    Dracopoli NC
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S57-60. PubMed ID: 12856151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methodological and statistical issues in pharmacogenomics.
    Peters BJ; Rodin AS; de Boer A; Maitland-van der Zee AH
    J Pharm Pharmacol; 2010 Feb; 62(2):161-6. PubMed ID: 20487194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics for individualized cancer chemotherapy.
    Efferth T; Volm M
    Pharmacol Ther; 2005 Aug; 107(2):155-76. PubMed ID: 15890408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetic analysis of clinically relevant genetic polymorphisms.
    McLeod HL
    Clin Infect Dis; 2005 Nov; 41 Suppl 7():S449-52. PubMed ID: 16237646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent development in pharmacogenomics: from candidate genes to genome-wide association studies.
    Grant SF; Hakonarson H
    Expert Rev Mol Diagn; 2007 Jul; 7(4):371-93. PubMed ID: 17620046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the pharmacogenetics of cancer chemotherapy.
    Watters JW; McLeod HL
    Curr Opin Mol Ther; 2002 Dec; 4(6):565-71. PubMed ID: 12596358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis pharmacogenomics: maximizing efficacy of therapy.
    Pappas DJ; Oksenberg JR
    Neurology; 2010 Jan; 74 Suppl 1():S62-9. PubMed ID: 20038765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics: historical perspective and current status.
    Charlab R; Zhang L
    Methods Mol Biol; 2013; 1015():3-22. PubMed ID: 23824846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics of cancer chemotherapy-induced toxicity.
    Miller CR; McLeod HL
    J Support Oncol; 2007 Jan; 5(1):9-14. PubMed ID: 17265780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpreting disparate responses to cancer therapy: the role of human population genetics.
    Maitland ML; DiRienzo A; Ratain MJ
    J Clin Oncol; 2006 May; 24(14):2151-7. PubMed ID: 16682733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.